Check out a recap of important pharmacy news you might’ve missed this week, dispensed in small doses.
Brexpiprazole Plus Sertraline for PTSD Submitted to FDA for sNDA Review
Two trials studying brexpiprazole in combination with sertraline "constitute one of the largest clinical development programs ever conducted in posttraumatic stress disorder (PTSD)."
Is E-Prescribing the Future of Veterinary Medicine?
Wendy Crouse, DVM, an independent house call veterinarian with Heal House Call Veterinarian, sat down with Drug Topics to discuss how the adoption of e-prescribing has transformed her practice.
Q&A: Inside the Vanderbilt Specialty Pharmacy-AstraZeneca Collaboration
A siloed approach to care can worsen patient outcomes, but collaboration between one health system specialty pharmacy and a manufacturer led to better patient care.
The Importance of Continuing Education in Pharmacy Compounding
Kevin Hope, RPh, senior director of pharmacy education at Pharmcon, joined Drug Topics to discuss pharmacy compounding from the new USP changes and the importance of education around compounding best practices.
Weight-Loss Drugs Fuel Rise in US Prescription Spending
The rise of weight-loss drugs has overtaken the US prescription drug market and significantly increased spending from 2022 to 2023.
CGM Use Linked to Improved Diabetic Retinopathy Outcomes in T1D
The current study highlights the potential benefit of incorporating continuous glucose monitor (CGM) data into eye care assessments for patients with type 1 diabetes (T1D).